Market Overview:

The Anastomosis Devices Market is experiencing significant expansion, driven by Rising Incidence of Cancer, Growing Geriatric Population and Increasing Prevalence of Cardiovascular Diseases. According to IMARC Group's latest research publication, "Anastomosis Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global anastomosis devices market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/anastomosis-devices-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Anastomosis Devices Industry:

• Rising Incidence of Cancer

The rising number of cancers is increasing the demand for surgeries involving anastomosis devices. The World Health Organization's (WHO) cancer agency, the International Agency for Research on Cancer (IARC), released a report on the most recent numbers on the worldwide cancer burden. According to IARC's 2022 estimates, which use the most trustworthy data sources from various nations, the rising number of cancers particularly affects underserved populations. For instance, in 2022, it is estimated that there were 20 million new cancer diagnoses and 9.7 million deaths due to cancer. It is estimated that 53.5 million people will survive up to 5 years after being diagnosed with cancer. According to statistics, one in every five individuals will get cancer at some point in their life, with one in every nine men and one in every twelve women dying of it. As a result, this increases the need for surgical treatments utilizing anastomosis devices throughout the globe.

• Growing Geriatric Population

The growing global geriatric population is also influencing the anastomosis devices market value. According to the United Nations' assessment, the global geriatric population is projected to expand from 761 million in 2021 to 1.6 billion by 2050. Also, in 2021, approximately 1 out of every 10 people globally was 65 years old or older which is projected to increase by 2050 as 1 out of every 6 individuals worldwide. This demographic change results in a larger frequency of age-related illnesses, necessitating more surgical operations including anastomosis devices. Additionally, elderly people frequently experience health problems such as gastrointestinal disorders or cardiovascular ailments, which may necessitate surgical intervention. As a result, the market for anastomosis devices is expected to grow in unison with the aging population, thus positively affecting anastomosis devices market revenue.

• Increasing Prevalence of Cardiovascular Diseases

The rising prevalence of cardiovascular diseases (CVDs) is escalating the demand for anastomosis devices used in cardiovascular surgery. According to British Heart Foundation research published in January 2024, around 7.6 million individuals in the United Kingdom (UK) suffer from heart and circulatory diseases. Currently, the gender distribution is roughly equal, with around 4 million men and 3.6 million women affected. Heart and circulation illnesses are a major cause of death, accounting for around 27% of all fatalities in the United Kingdom. This equates to more than 170,000 fatalities every year, or around 480 each day, or one fatality every 3 minutes. As a result, there is a rising need to treat these problems, necessitating surgical procedures that raise the need for anastomosis devices during cardiovascular surgery to restore blood flow and enhance heart function. As the prevalence of CVDs rises owing to sedentary lifestyles and poor eating habits, so will be the need for anastomosis devices for surgeries.

Key Trends in the Anastomosis Devices Market

• Adoption of Surgical Staplers

Surgical staplers influence the segment due to their broad use in numerous surgical procedures. Surgical staplers are popular because they are efficient, precise, and can minimize operational time and postoperative difficulties when compared to conventional sutures. These devices enable rapid and secure anastomosis, which is critical in procedures including gastrointestinal, cardiac, and thoracic surgery. For example, on 27 May 2024, Ethicon, a Johnson & Johnson MedTech firm, introduced the ECHELON LINEAR Cutter in the United States. This is the industry's first linear cutter to use two distinct technologies, including 3D-Stapling Technology and Gripping Surface Technology (GST). These methods have been shown to improve the security of staple lines, potentially lowering surgical complications and enhancing patient outcomes. The device is scientifically supported and has been shown to reduce leaks at the staple line by 47%, decreasing surgical risks.

• Focus on Cardiovascular and Thoracic Surgery Applications

Cardiovascular and thoracic surgeries dominate the market growth due to the high prevalence of cardiovascular diseases, such as coronary artery disease and heart failure, which necessitate surgical interventions. Cardiovascular and thoracic surgeries often require precise reconnection of blood vessels or other tubular structures, making anastomosis devices critical for successful outcomes. Innovations in device technology, such as the development of automated and minimally invasive anastomosis devices, further drive the adoption of these procedures. Additionally, the increasing aging population, which is more susceptible to cardiovascular conditions, contributes to the growing demand for these devices in cardiovascular and thoracic surgeries. As per the study released by the National Library of Medicine in August 2023, Coronary Artery Bypass Grafting (CABG) is the most common surgical procedure with approximately 400,000 CABG surgeries conducted annually.

• Expansion in Hospital End-User Segment

Hospitals represent the largest segment due to the high volume of surgical procedures performed in hospitals, including cardiovascular, gastrointestinal, and other critical surgeries where anastomosis devices are essential. For instance, as per the American Hospital Association, 6,120 hospitals are there in the United States. Moreover, hospitals are equipped with advanced surgical facilities and skilled healthcare professionals who frequently utilize numerous devices for creating surgical connections between tissues and organs. Furthermore, the infrastructure in hospitals supports the use of sophisticated devices, which facilitates the efficient and effective handling of complex surgical tasks. As a result, the demand for anastomosis devices within hospital settings continues to grow due to the increasing number of surgeries and the ongoing advancements in surgical techniques and device innovation.

We explore the factors driving the growth of the market, including technological advancements, consumer behaviors, and regulatory changes, along with emerging anastomosis devices market trends.

Leading Companies Operating in the Global Anastomosis Devices Industry:

• Artivion Inc.
• B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson and Company
• Getinge AB
• Intuitive Surgical Inc.
• Johnson & Johnson
• Meril Life Sciences Pvt. Ltd.
• Peters Surgical
• Synovis Micro Companies Alliance Inc. (Baxter International Inc.)

Anastomosis Devices Market Report Segmentation:

By Type:

• Surgical Staplers
  • Manual
  • Powered
• Surgical Sutures
  • Absorbable Sutures (Synthetic Sutures, Natural Sutures)
  • Non-absorbable Sutures (Polypropylene, Nylon, Stainless Steel, Others)
• Automated Suturing Devices
  • Disposable
  • Reusable
• Surgical Sealants and Adhesives
  • Natural/Biological (Fibrin-based, Collagen-based, Albumin-based)
  • Synthetic and Semisynthetic (PEG Hydrogel-based, Cyanoacrylate-based, Others)

Surgical staplers represent the largest segment as they are efficient, precise, and can minimize operational time and postoperative difficulties when compared to conventional sutures.

By Application:

• Gastrointestinal Surgeries
• Cardiovascular and Thoracic Surgeries
• Others

Cardiovascular and thoracic surgeries hold the biggest market share due to the high prevalence of cardiovascular diseases that necessitate surgical interventions.

By End User:

• Hospitals
• Ambulatory Surgical Centers and Clinics
• Others

Hospitals account for the largest market share, driven by the high volume of surgical procedures performed in hospitals and advanced surgical facilities.

Regional Insights:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the anastomosis devices market on account of advanced healthcare infrastructure and a high volume of surgical procedures.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201-971-6302